Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection

J Immunol. 1996 May 1;156(9):3342-9.

Abstract

Murine hepatitis virus strain 3 (MHV-3) produces a strain-dependent spectrum of disease. The development of liver necrosis has been shown to be related to production of a unique macrophage procoagulant activity (PCA), encoded by the gene fgl-2, in susceptible mice. These studies were designed to examine the influence of Th1/Th2 cells on resistance/susceptibility and production of macrophage PCA in resistant (A/J) and susceptible (BALB/cJ) strains of mice following infection with MHV-3. Immunization of A/J mice with MHV-3 induced a Th1 cellular immune response, and one Th1 cell line (3E9.1) protected susceptible mice and inhibited PCA production by macrophages both in vitro and in vivo. In contrast, immunization of BALB/cJ mice with an attenuated variant of MHV-3 derived from passaging MHV-3 in YAC-1 cells resulted in a Th2 response. Transfer of spleen cells and T cell lines from immunized BALB/cJ mice failed to protect naive susceptible syngeneic mice from infection with MHV-3 and augmented macrophage PCA production to MHV-3 in vitro. However, serum from immunized BALB/cJ mice contained high titrated neutralizing Ab that protected naive BALB/cJ animals from lethal primary MHV-3 infection. These results demonstrate that susceptible BALB/cJ mice generate a Th2 response following MHV-3 infection and that these Th2 cells neither inhibit MHV-3-induced macrophage PCA production nor protect naive mice from MHV-3 infection. The results suggest that Ab protects against primary infection but cannot eradicate ongoing infection. Thus, these data define the differential role of Th1/Th2 lymphocytes in primary and secondary MHV-3 infection and emphasize the importance of PCA in the pathogenesis of MHV-3 infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Viral / therapeutic use*
  • Blood Coagulation Factors / biosynthesis
  • Blood Coagulation Factors / immunology
  • Cell Line
  • Coronavirus Infections / immunology*
  • Disease Susceptibility
  • Female
  • Hepatitis, Viral, Animal / immunology*
  • Hepatitis, Viral, Animal / prevention & control*
  • Immunity, Innate
  • Immunization, Passive
  • Immunotherapy, Adoptive
  • Macrophages / immunology
  • Mice
  • Mice, Inbred A
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Murine hepatitis virus / immunology*
  • Spleen / transplantation
  • Th1 Cells / immunology*
  • Th1 Cells / virology
  • Th2 Cells / immunology*
  • Th2 Cells / virology
  • Viral Vaccines / immunology*

Substances

  • Antibodies, Viral
  • Blood Coagulation Factors
  • Viral Vaccines
  • macrophage procoagulant activity